Robert McEwen
Impact in
- Physiology top 2%
- Calcium signaling and nucleotide metabolism
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 5
- Fungal and yeast genetics research 3
- Protein Kinase Regulation and GTPase Signaling 3
-
- Advanced Breast Cancer Therapies 9
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Robert H. Michell (5 shared papers)Stephen K. Dove (5 shared papers)Jonathan R. Dry (5 shared papers)J. Carl Barrett (4 shared papers)Brian Dougherty (4 shared papers)Zhongwu Lai (2 shared papers)Peter J. Parker (4 shared papers)Frank T. Cooke (4 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Oncotarget (4 papers)Cancer Research (4 papers)Molecular Cancer Therapeutics (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Robert McEwen
38 papers receiving 2.2k citations
Robert McEwen's Hit Papers
Peers
Comparison fields: 5 of 93
- Physiology 193
- Cancer Research 561
- Cell Biology 571
- Oncology 509
- Molecular Biology 1.0k
Countries citing papers authored by Robert McEwen
This map shows the geographic impact of Robert McEwen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert McEwen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert McEwen more than expected).
Fields of papers citing papers by Robert McEwen
This network shows the impact of papers produced by Robert McEwen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert McEwen. The network helps show where Robert McEwen may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert McEwen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research Hit paper breakdown → | 2016 | 525 |
| 2 | 2004 | 279 | |
| 3 | 1998 | 185 | |
| 4 | 2018 | 132 | |
| 5 | 2002 | 115 | |
| 6 | 2017 | 106 | |
| 7 | 2015 | 105 | |
| 8 | 2019 | 104 | |
| 9 | 2022 | 97 | |
| 10 | 1999 | 95 | |
| 11 | 2016 | 83 | |
| 12 | 2020 | 69 | |
| 13 | 2020 | 56 | |
| 14 | 2016 | 37 | |
| 15 | 2018 | 37 | |
| 16 | 1997 | 32 | |
| 17 | 2016 | 32 | |
| 18 | 2013 | 31 | |
| 19 | 2017 | 25 | |
| 20 | 2019 | 25 |
About Robert McEwen
Robert McEwen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Genetics, having authored 38 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Advanced Breast Cancer Therapies (9 papers), Cellular transport and secretion (5 papers), Lung Cancer Treatments and Mutations (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer-related Molecular Pathways (4 papers), Fungal and yeast genetics research (3 papers) and Protein Kinase Regulation and GTPase Signaling (3 papers). The work is most often cited by research in Physiology (193 citations), Cancer Research (561 citations), Cell Biology (571 citations), Oncology (509 citations) and Molecular Biology (1.0k citations). Robert McEwen has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Robert H. Michell, Stephen K. Dove, Jonathan R. Dry, J. Carl Barrett, Brian Dougherty, Zhongwu Lai, Peter J. Parker, Frank T. Cooke, Andrew B. Holmes and Miika Ahdesmäki. Their work appears in journals such as Journal of Clinical Oncology, Oncotarget, Cancer Research, Molecular Cancer Therapeutics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.